FDA Inspection 1034059 — Daniel Rutrick, MD
The FDA completed an inspection of Daniel Rutrick, MD on Sep 12, 2017 in Watertown, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Watertown, MA (United States)
Additional details
Clinical Investigator (CI)